[1] Li X, Zhou TC, Wu CH, et al.Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China.Sci Rep,2018,8:869. [2] 杨年欢,袁国盛,周宇辰.恩替卡韦联合复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化96周的临床疗效.南方医科大学学报,2016,36:775-779. [3] 谌翠容,过建春,俞秀丽.恩替卡韦联合复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化疗效观察.浙江中医药大学学报,2010,34:370-371. [4] Zhao M, Zhang ZZ, Liu QB.Role of long noncoding RNA in chronic hepatitis B infection. Zhonghua Er Ke Za Zhi,2018,56:67-69. [5] 黄凌鹰,张鑫,周振华,等.瞬时弹性成像系统评价复方鳖甲软肝片联合恩替卡韦抗慢性乙型肝炎肝纤维化的疗效研究.河北中医,2017,39:1827-1831. [6] 孙燕燕,朱振霞.恩替卡韦联合复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化的临床疗效.临床合理用药杂志,2017,10:67-68. [7] 张世应,张书勤.复方鳖甲软肝片联合恩替卡韦治疗HBeAg阴性乙型肝炎肝纤维化疗效及对血清炎性因子的影响.中国药业,2017,26:75-77. [8] 赵建学,吴意赟,陆玮婷,等.恩替卡韦联合复方鳖甲软肝片对HBV DNA阳性慢性乙型肝炎肝纤维化患者脾脏弹性指数及门静脉内径的影响.南京医科大学学报(自然科学版),2017,37:1504-1506. [9] 路慎国.复方鳖甲软肝片联合恩替卡韦治疗乙肝后肝硬化的疗效研究.智慧健康,2017,3:108-109. [10] 王国良,兑丹华,倪平志,等.恩替卡韦联合复方鳖甲软肝片治疗乙肝肝硬化Meta分析.贵州医药,2017,41:968-970. |